These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26050311)

  • 1. [Financing of continuing education].
    Kherad O; De Benedetti E; Perrier A
    Rev Med Suisse; 2015 Apr; 11(470):888. PubMed ID: 26050311
    [No Abstract]   [Full Text] [Related]  

  • 2. Don't restrict funding from drug companies for doctors' education.
    Skolnik N
    BMJ; 2013 Nov; 347():f6452. PubMed ID: 24212106
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmaceutical industry and the medical profession.
    Phatak A
    Issues Med Ethics; 1998; 6(4):131-2. PubMed ID: 16267942
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuing education, industry, and physicians.
    DeMaria AN
    J Am Coll Cardiol; 2008 Sep; 52(12):1035-6. PubMed ID: 18786488
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug company sponsorship of education could be replaced at a fraction of its cost.
    Moynihan R
    BMJ; 2003 May; 326(7400):1163. PubMed ID: 12775595
    [No Abstract]   [Full Text] [Related]  

  • 6. Doctors, drug companies and medical ethics: a Sri Lankan perspective.
    Malavige GN
    Indian J Med Ethics; 2004; 1(1):26. PubMed ID: 16370067
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical communication companies and continuing medical education: clouding the sunshine?
    Schwartz LM; Woloshin S
    JAMA; 2013 Dec; 310(23):2507-8. PubMed ID: 24346987
    [No Abstract]   [Full Text] [Related]  

  • 8. Future directions in industry funding of continuing medical education.
    Steinbrook R
    Arch Intern Med; 2011 Feb; 171(3):257-8. PubMed ID: 21325116
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugmakers and continuing medical education.
    Mehta PN
    Indian Pediatr; 2000 Jun; 37(6):626-30. PubMed ID: 10869142
    [No Abstract]   [Full Text] [Related]  

  • 10. Industry spending on continuing medical education in US falls further.
    Roehr B
    BMJ; 2012 Aug; 345():e5336. PubMed ID: 22872716
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical education companies got $170m in grants from 14 drug firms in 2010, study finds.
    Kmietowicz Z
    BMJ; 2013 Dec; 347():f7534. PubMed ID: 24353103
    [No Abstract]   [Full Text] [Related]  

  • 12. CME shelter. Sunshine Act waiver for med ed payments may prompt marketing shift for product makers.
    Lee J
    Mod Healthc; 2014 Jun; 44(26):16-9. PubMed ID: 25134407
    [No Abstract]   [Full Text] [Related]  

  • 13. Physicians and the pharmaceutical industry.
    Berman JL
    Ann Intern Med; 1990 Dec; 113(11):900. PubMed ID: 2240912
    [No Abstract]   [Full Text] [Related]  

  • 14. Successes, challenges emerge from efforts to shift away from industry-funded CME.
    Kuehn BM
    JAMA; 2010 Aug; 304(7):729-31. PubMed ID: 20716730
    [No Abstract]   [Full Text] [Related]  

  • 15. Financial relationships between medical communication companies and industry.
    Love N
    JAMA; 2014 Apr 23-30; 311(16):1692. PubMed ID: 24756522
    [No Abstract]   [Full Text] [Related]  

  • 16. Financial relationships between medical communication companies and industry.
    Kopelow M
    JAMA; 2014 Apr 23-30; 311(16):1691-2. PubMed ID: 24756521
    [No Abstract]   [Full Text] [Related]  

  • 17. Whose pen is being used to write your prescriptions? Nominal gifts, conflicts of interest, and continuing medical education.
    Davar M
    J Leg Med; 2008; 29(2):199-217. PubMed ID: 18569441
    [No Abstract]   [Full Text] [Related]  

  • 18. Financial relationships between medical communication companies and industry--reply.
    Rothman SM
    JAMA; 2014 Apr 23-30; 311(16):1692-3. PubMed ID: 24756523
    [No Abstract]   [Full Text] [Related]  

  • 19. The sum of us: considerations on physician-industry relationships.
    Flores Rebollar A
    Medwave; 2017 May; 17(4):e6961. PubMed ID: 28582384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: medical communication companies and industry grants.
    Penson DF
    J Urol; 2014 Jul; 192(1):191. PubMed ID: 25629121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.